On the recordJuly 27, 2011
But is it the agency's policy to ignore the statute in the law?
Source
congress.govBut is it the agency's policy to ignore the statute in the law?
Challenging the FDA's adherence to statutory guidelines.
Share
More from Richard Burr
When the Reagan revolution came to the Senate, Orrin Hatch became the Committee's Chair.
Ms. Kotagal's refusal to continue these common-sense measures speaks volumes of her lack of commitment to due process and transparency.
The faster, more predictable, and more accountable the programs are, the more patients stand to benefit from lifesaving, innovative drugs and devices.